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Abstract 
Gani, J., A note on a stochastic model for the incubation of transfusion-associated AIDS, 
Discrete Mathematics 92 (1991 j 89-94. 
The model-based approach of Lui, Peterman, Lawrence and Allen (198Sj to the transfusion- 
associated incubation period of AIDS, and the mechanism of HIV infectivity outlined by 
Margolick, Bowen, Lane and Fauci (1986), and Fauci (1988), suggest hat a stochastic process 
may account for the depletion of the T-lymphocytes before AIDS symptoms are detected. This 
paper considers a simple death process as an example. After estimating the relevant 
parameters, the fit of this process to the given data proves to be satisfactory. 
1. Introduction 
In their recent paper, Lui, Peterman, Lawrence and Allen [3] have shown that 
data on the incubation periods of 32 paediatric transfusion-associated AIDS 
(TA-AIDS) patients could be fitted empirically by a Weibull density function of 
the form 
f(t, A, r, 0) = h-(t - ~)r-‘e-A(‘-ey, 8 c f < =. 
Here 0 is the minimum number of months after exposure before a diagnosis can 
occur, t is the incubation period in months and A, r > 0 are parameters of the 
distribution. 
Maximum likelihood estimates of the mean incubation period fi, and of the 
relevant parameters of f(r, A, r, 0) were found to ,:e 
fi = 29 months, i= 1.418 5i=O.O0856, 8=3months 
0012-365X/91/$03.50 0 1991- Elsevier Science Publishers B.V. All rights reserved 
90 3. Gani 
respectively. The auIIIvIo Yv..lr v +hfi= w;n+nut the advantages of their model-based analysis 
of the available data. Margolick, Bowen, Lane and Fauci’s [4], and Fauci’s [l] 
descriptions of the HIV infectivity mechanism suggests that the depletion process 
of the T-lymphocytes (T-4) in patients may help to provide a theoretical 
foundation for the distribution of the TA-AIDS incubation period. 
The T-lymphocyte count per mm3 in a typical patient exposed to HIV tends to 
drop and then rebound directly after the patient’s infection, with a gradual 
subsequent decline, until the count remains chronically below 400. At this stage, 
overt symptoms of AIDS develop. The T-lymphocyte count is a stochastic process 
which could perhaps be most accurately modelled by a birth-death process with 
time-dependent birth and death parameters A(t), p(t) respectively for ta0. It 
seems likely that A(J) first increases and then declines, while p(c) increases 
steadily with time t. While this model would undoubtedly be quite realistic, and 
probably provide a close fit to the data, we shall by way of an example, construct 
the simplest possible model to account for the distribution of the incubation 
period (based on a pure death model for the T-lymphocytes), and then perform a 
goodness of fit test on the Lui, Peterman, Lawrence and Allen [3] data to validate 
it. 
2. A pnre death process for T-lymplmytes 
Suppose that TA-AIDS is diagnosed when the number of T-lymphocytes in an 
individual decreases to a level below the threshold ~~ (fixed), and that in healthy 
individuals the number N of T-lymphocytes is random with a Poisson distribution 
of parameter 1. Thus 
P(N=y)=emAx 
y! ’ 
y=O,l,..., (2-l) 
where E(N) = L. 
Once a patient with N lymphocytes is infected, this number begins to decline as 
a pure death stochastic process with parameter p, so that after a period t >O, 
XN(t) 6 N lymphocytes remain alive with probability distribution 
P{X,(f) =x) = (f)(e-‘)“(l - e-p)N-x, x = 0, 1, . . . , N. 
It is well known that when N 2 x0, the period r until X,(t) decreases to a level 
below x0, that is X,(r) = x0 - 1, has the density function 
&Jr) = P{Xiv(r) =x0]!% 
= d-J 1 (e-“‘)““(I _ e-Pr)N--xnpo, OSZ<% (2.2) 
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Now, since N was assumed to be a Poisson random variable as in (2.1), the 
density function (2.2) averaged over all individuals with N 5 x, will be 
(2.31 
namely a form of truncated gamma distribution in the variable Cl c AemMr d rt. 
When N<xo, we have the probability 
(2.4) 
that TA-AIDS symptoms occur immediately. It is readily shown that for our 
mixed discrete-continuous distribution of r, 
PO+ g(r)dz= 1. 
To simplify our model even further, let us take the value x0 as our basic unit, and 
measure N in terms of it, so that our new N = 1,2, . . . , now corresponds to 
x0,2&, * - - 9 T-lymphocytes. Then with this change in units, and the consequent 
modification of the parameters, we have 
g(r) = e-~e-“j&-lrr 0 < r C 03, (2.5) 
and 
Po=e-‘, r=O. (2.6) 
We shall show that even in this oversimplified case, the known data is fitted 
satisfactorily, so that in general (2.3) and (2.4) should provide a more 
sophisticated fit when the lymphocyte units are finer. It should also be pointed 
out that, as Lagakcs, Bar@ and de Gruttola [2] have noted among others, the 
observed data is truncated, and inference from it will give a biased distribution of 
the TA-related incubation period of AIDS. We avoid this important issue here, 
and concentrate on demonstrating that a simple stochastic model of the 
T-lymphocyte count can lead to an adequate fit of the observed data. 
3. The data and the simplest model 
From the data tabulated by Lui, Petcrman, Lawrence and Allen [3], we cau 
conclude that the frequency distribution of the 32 incubation periods (in years) 
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was: 
Observed frequency of incubation periods 
Incubation in years: 0 1 2 3 4 5 
Frequency: 4 13 9 4 1 I 
We may, using (2.5) and (2.6) estimate A and p from the above data as follows. 
We set 
_ 
32 
(I 
e-aee-rr~Ae-P’ dt = 28 
0.5 
(3.1) 
or 
We now take the first moment of the frequencies 
J = 32 [ e-‘~-*TA~e-Prdr, i = 1,2,3,4, 
i-O.5 
and 
as 
f5 = 32 i e-JL”-“Ape-fl” dt 
4.5 
+ 3(e-~+r _ e-ae-2 5’) + 4(e-ae-“sp _ e-“-3 5”) 
+ 5( 1 - e-*ee-4’“r)} = 52, 
e-Aee-O-sp + e-“‘-’ SC + e-Ae+‘sp + e-ae-‘s” + e-ac-4.cp = 3.375. (3.2) 
From (3.1) and (3.2) we find 
A = 3.705, p = 1.155 
with the mean incubation time of 1.625 years or 19.5 months. Had the exact 
lengths of the incubation periods rj (j = 1, . . . ,32) been recorded, maximum 
likelihood estimators of A and ,u could be derived from (2.5); but for our purpose 
the present crude estimates will suffice. 
We can now obtain the expected frequencies & of the incubation periods 
A note on a stochastic model 93 
lasting 1, 2, 3, 4, 5 years: 
Expected frequency of incubation periods 
incubation in years: 0 1 2 3 4 5 
Frequency: 4 12.62 9.41 3.95 1.36 0.65 
Here 
fo = 32[ 1 - i e-‘e-rr~~e-pr dt) 
0.5 
will be identical with the observed value 4, since this had been used to estimate A 
and p above in (3.1). 
The value of x2 for the goodness of fit test now gives 
~5 = 0.3156 on 3 degrees of freedom; 
we note that for x$ the critical value at the 10% level of significance is 6.25. Thus, 
even this very simple pure death model, with its extremely crude estimation 
method gives a reasonable fit. Refinements in which the unit mesh is finer, and t 
is replaced by t - 8 in (2.5), to take account of the minimum time 8 between 
exposure and diagnosis would improve the model. Likewise, the replacement of 
the pure death T-lymphocyte model by a more realistic birth-death model with 
time-dependent parameters, should also lead to further improvement. 
4. Discussion 
Lui, Peterman, Lawrence and Allen’s [3] model-based approach is an advance 
on the traditional descriptive statistics provided for the incubation period of 
TA-AIDS. However, recourse to a simple stochastic model based on the 
depletion of T-lymphocytes provides a formula for the distribution of the 
incubation period r which is simple, theoretically sound and fits the data. Such a 
stochastic model offers a reasonable explanation of the distribution of incubation 
periods, in keeping with the known decrease of T-lymphocytes in TA-AIDS 
patients. 
So far as one can judge from Margolick, Bowen, Lane and Fauci’s 14, Fig:. 1 j, 
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the following are the average counts of T-lymphocytes for 
Controls 1202/mm3 
Patients with chronic lymphadenopathy syndrome 660/mm3 
Patients with Kaposi’s sarcoma 240/mm3 
Patients with opportunistic infections 32/mm3 
Thus a rough average of counts for AIDS patients gives 311/mm3. We note that 
the controls have approximately 3.87 times the T-lymphocyte count of the AIDS 
patients, a result which is in rough agreement with our fi = 3.705. 
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